Medidata Solutions Inc. (MDSO)

91.72
NASDAQ : Technology Services
Prev Close 91.75
Day Low/High 91.63 / 91.79
52 Wk Low/High 60.10 / 98.60
Avg Volume 1.26M
Exchange NASDAQ
Shares Outstanding 62.46M
Market Cap 5.73B
EPS 0.90
P/E Ratio 127.35
Div & Yield N.A. (N.A)

Latest News

Who's Next?: Acquisition Rumors Abound After IBM's $34 Billion Red Hat Splash

Who's Next?: Acquisition Rumors Abound After IBM's $34 Billion Red Hat Splash

The momentum of acquisitions isn't stalling. Here's what names might be in the mix.

Medidata downgraded at Jefferies

Medidata upgraded at Topeka

Medidata downgraded at Jefferies

Three to Avoid in the Nosebleed Section

There's no justifying valuations at these lofty levels.

Egregiously Overvalued Stocks to Avoid

The first installment of my list includes biotech, Internet and insurance.

Momentum Tech Stocks Stage a Revival

Here are a few reasons why these volatile names are once again on the upswing.

Everyone Wants a Slice of Cloud Cash

Everyone Wants a Slice of Cloud Cash

Will Hewlett-Packard emerge from the fog in time to tackle Amazon and Google?

Watch the Trading Volumes

Watch the Trading Volumes

These data will indicate if things are going to perk up or if we are in for more warnings.

When Bad News Is a Buying Opportunity

When Bad News Is a Buying Opportunity

Do your research on the underlying companies, especially during earnings season.

Fitz Bits: A Troubling Advance

Fitz Bits: A Troubling Advance

The absence of committed bears is a worry.

Cyber-Security Stocks Aren't so Safe

Cyber-Security Stocks Aren't so Safe

They're the latest group of companies to get hit.

Take General Motors for a Spin

Take General Motors for a Spin

Investors looking to jump onto the automotive cycle should scoop up the shares and hang on for the ride.

The Cloud Is the Prescription

The Cloud Is the Prescription

Medidata Solutions is focusing its cloud-computing offerings on the pharmaceutical industry.

The Week Ahead: A Troubling Guidance Trend

The vast bulk of S&P 500 outlooks are undershooting consensus.

Pounce on the Anointed Ones

These stocks look bound to get bought at every dip through year-end. You should buy up, too -- but wait for that swoon.

Mad Money: Medidata & Marketo

Mad Money: Medidata & Marketo

Jim Cramer says Medidata and Marketo represent growth opportunities in a discussion with the 'Mad Money' research director, Nicole Urken.

Covance Not Cooling Off

Covance Not Cooling Off

Covance CEO Joe Herring says the drug development company is expanding in the emerging markets as well as the cloud.

Medidata Pushing Clinical Cloud

Medidata Pushing Clinical Cloud

Medidata Solutions CEO Tarek Sherif discusses the company's blowout Q1 earnings report as well as the expansion of the "Clinical Cloud".

Medidata upgraded at Piper